Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $46.8050 (1.95%) ($46.8050 - $46.8100) on Thu. Jun. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.39% (three month average) | RSI | 53 | Latest Price | $46.8050(1.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1% a day on average for past five trading days. | Weekly Trend | HALO declines -0.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(45%) IWM(40%) IWO(40%) IWC(38%) IWN(38%) | Factors Impacting HALO price | HALO will decline at least -1.195% in a week (0% probabilities). VIXM(-18%) UUP(-7%) VXX(-6%) TBT(-2%) EDOC(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.195% (StdDev 2.39%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $45.16(3.64%) | 10 Day Moving Average | $44.63(4.87%) | 20 Day Moving Average | $45.3(3.32%) | To recent high | -3.1% | To recent low | 25.3% | Market Cap | $6.397b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |